Log In
Print this Print this

esuberaprost (formerly Beraprost 314d)

  Manage Alerts
Collapse Summary General Information
Company United Therapeutics Corp.
DescriptionReformulated, single isomer verson of beraprost
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule
Latest Stage of DevelopmentPhase III
Standard IndicationHypertension
Indication DetailsTreat pulmonary arterial hypertension (PAH)
Regulatory Designation
PartnerToray Industries Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today